Patents by Inventor Susanne Klint

Susanne Klint has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-17A-BINDING POLYPEPTIDES
    Publication number: 20210253659
    Abstract: The present disclosure relates to a class of engineered polypeptides having a binding affinity for interleukin-17A (IL-17A), and provides an IL-17A binding polypeptide comprising the sequence EX2DX4AX6X7EIX10X11LPNL X16X17X18QX20X21AFIX25X26LX28X29. Also disclosed is the use of such an interleukin-17A binding polypeptide as a diagnostic, prognostic and/or therapeutic agent.
    Type: Application
    Filed: February 1, 2021
    Publication date: August 19, 2021
    Inventors: Fredrik Frejd, Joachim Feldwisch, Susanne Klint, Lindvi Gudmundsdotter
  • IL-17A-binding polypeptides
    Patent number: 10934335
    Abstract: The present disclosure relates to a class of engineered polypeptides having a binding affinity for interleukin-17A (IL-17A), and provides an IL-17A binding polypeptide comprising the sequence EX2DX4AX6X7EIX10X11 LPNL X16X17X18QX20X21AFIX25 X26LX28X29. Also disclosed is the use of such an interleukin-17A binding polypeptide as a diagnostic, prognostic and/or therapeutic agent.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: March 2, 2021
    Assignee: AFFIBODY AB
    Inventors: Fredrik Frejd, Joachim Feldwisch, Susanne Klint, Lindvi Gudmundsdotter
  • Polypeptide
    Patent number: 10669314
    Abstract: The present disclosure relates to a class of engineered polypeptides having a binding affinity for interleukin-6, and provides an IL-6 binding polypeptide comprising the sequence EEX3X4AWX7EIH X11 LPNLX16X17X18QX20 X21AFIX25X26LX28X29. The present disclosure also relates to the use of such an IL-6 binding polypeptide as a therapeutic, prognostic and/or diagnostic agent.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: June 2, 2020
    Assignee: AFFIBODY AB
    Inventors: Fredrik Frejd, Elin Gunneriusson, Ingmarie Höidén-Guthenberg, Per-Ake Nygren, Susanne Klint, Feifan Yu
  • IL-17A-BINDING POLYPEPTIDES
    Publication number: 20170362290
    Abstract: The present disclosure relates to a class of engineered polypeptides having a binding affinity for interleukin-17A (IL-17A), and provides an IL-17A binding polypeptide comprising the sequence EX2DX4AX6X7EIX10X11 LPNL X16X17X18QX20X21AFIX25 X26LX28X29. Also disclosed is the use of such an interleukin-17A binding polypeptide as a diagnostic, prognostic and/or therapeutic agent.
    Type: Application
    Filed: January 12, 2016
    Publication date: December 21, 2017
    Inventors: Fredrik Frejd, Joachim Feldwisch, Susanne Klint, Lindvi Gudmundsdotter
  • NEW POLYPEPTIDE
    Publication number: 20170114099
    Abstract: The present disclosure relates to a class of engineered polypeptides having a binding affinity for interleukin-6, and provides an IL-6 binding polypeptide comprising the sequence EEX3X4AWX7EIH X11 LPNLX16X17X18QX20 X21AFIX25X26LX28X29. The present disclosure also relates to the use of such an IL-6 binding polypeptide as a therapeutic, prognostic and/or diagnostic agent.
    Type: Application
    Filed: June 15, 2015
    Publication date: April 27, 2017
    Inventors: Fredrik Frejd, Elin Gunneriusson, Ingmarie Höidén-Guthenberg, Per-Ake Nygren, Susanne Klint, Feifan Yu